Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Key Residues Controlling Binding of Diverse Ligands to Human Cytochrome P450 2A Enzymes

N. M. DeVore, B. D. Smith, J. L. Wang, G. H. Lushington and E. E. Scott
Drug Metabolism and Disposition June 2009, 37 (6) 1319-1327; DOI: https://doi.org/10.1124/dmd.109.026765
N. M. DeVore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. D. Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. L. Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. H. Lushington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. E. Scott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 37 no. 6 1319-1327
DOI 
https://doi.org/10.1124/dmd.109.026765
PubMed 
19251817

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received January 14, 2009
  • Accepted February 26, 2009
  • Published online May 15, 2009.

Article Versions

  • Earlier version (February 27, 2009 - 08:21).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. N. M. DeVore,
  2. B. D. Smith,
  3. J. L. Wang,
  4. G. H. Lushington and
  5. E. E. Scott
  1. Department of Medicinal Chemistry (N.M.D., B.D.S., E.E.S.) and the Molecular Graphics and Modeling Laboratory (J.L.W., G.H.L.), University of Kansas, Lawrence, Kansas
  1. Address correspondence to:
    Dr. Emily E. Scott, Department of Medicinal Chemistry, University of Kansas, 1251 Wescoe Hall Dr., Lawrence, KS 66045. E-mail: eescott{at}ku.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2009 to May 2022

AbstractFullPdf
Feb 200911025
Mar 2009390113
Apr 200916045
May 200933751
Jun 200927817
Jul 200921517
Aug 200914814
Sep 20091348
Oct 200922716
Nov 200913913
Dec 20092836
Jan 201031217
Feb 2010221013
Mar 2010331016
Apr 20105977
May 20102159
Jun 2010141412
Jul 201020915
Aug 2010321812
Sep 201071611
Oct 201014125
Nov 201013186
Dec 201081710
Jan 2011152310
Feb 2011141415
Mar 201182223
Apr 201111129
May 2011251318
Jun 201191312
Jul 201124139
Aug 2011191912
Sep 201117125
Oct 2011132614
Nov 2011231414
Dec 2011201717
Jan 2012211419
Feb 2012361423
Mar 2012441918
Apr 201214611
May 2012251422
Jun 2012361421
Jul 2012201516
Aug 2012171716
Sep 2012181215
Oct 2012261113
Nov 201220811
Dec 2012261110
Jan 2013432421
Feb 201333258
Mar 2013251819
Apr 2013231212
May 20132989
Jun 20131685
Jul 20131275
Aug 201311510
Sep 20133555
Oct 20132095
Nov 20131739
Dec 201313922
Jan 201422311
Feb 201410810
Mar 20142123
Apr 20143159
May 20142463
Jun 20149122
Jul 20141590
Aug 20141041
Sep 2014121613
Oct 20142044
Nov 20141075
Dec 20141241
Jan 2015883
Feb 20151231
Mar 20151355
Apr 201520413
May 20158106
Jun 201510153
Jul 2015221110
Aug 2015993
Sep 20151161
Oct 2015741
Nov 20151222
Dec 20151246
Jan 2016848
Feb 20161096
Mar 20162410
Apr 2016687
May 201681110
Jun 20161098
Jul 2016664
Aug 2016849
Sep 2016383
Oct 20164124
Nov 2016061
Dec 20161102
Jan 20171104
Feb 2017581
Mar 201741110
Apr 20170113
May 2017073
Jun 2017096
Jul 20170115
Aug 2017191
Sep 20170121
Oct 2017172
Nov 20171191
Dec 2017273
Jan 2018080
Feb 2018271
Mar 2018185
Apr 20180143
May 20180167
Jun 20180175
Jul 2018175
Aug 20180153
Sep 20180354
Oct 20180365
Nov 20180610
Dec 201847121
Jan 20194912
Feb 20192801
Mar 20191800
Apr 20191323
May 20192014
Jun 2019913
Jul 2019812
Aug 20191400
Sep 20192403
Oct 20191510
Nov 20193013
Dec 20191702
Jan 20201944
Feb 20201022
Mar 2020810
Apr 20201306
May 2020400
Jun 20201410
Jul 2020813
Aug 2020706
Sep 2020931
Oct 20201646
Nov 20201401
Dec 20201411
Jan 20212094
Feb 202118125
Mar 20212121
Apr 2021920
May 20212161
Jun 20211740
Jul 20211533
Aug 20211471
Sep 2021640
Oct 20211273
Nov 202117102
Dec 20211341
Jan 20221010
Feb 20221521
Mar 20221112
Apr 20221673
May 20221141

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (6)
Drug Metabolism and Disposition
Vol. 37, Issue 6
1 Jun 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Key Residues Controlling Binding of Diverse Ligands to Human Cytochrome P450 2A Enzymes
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Key Residues Controlling Binding of Diverse Ligands to Human Cytochrome P450 2A Enzymes

N. M. DeVore, B. D. Smith, J. L. Wang, G. H. Lushington and E. E. Scott
Drug Metabolism and Disposition June 1, 2009, 37 (6) 1319-1327; DOI: https://doi.org/10.1124/dmd.109.026765

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Key Residues Controlling Binding of Diverse Ligands to Human Cytochrome P450 2A Enzymes

N. M. DeVore, B. D. Smith, J. L. Wang, G. H. Lushington and E. E. Scott
Drug Metabolism and Disposition June 1, 2009, 37 (6) 1319-1327; DOI: https://doi.org/10.1124/dmd.109.026765
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of Human MSRA on Sulindac Activation
  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics